Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report fr (Q52999892)
Jump to navigation
Jump to search
scientific article
- Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report fro
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report fr |
scientific article |
|
Statements
Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report fr (English)
1 reference
P S Gaynon
1 reference
J Nachman
1 reference
H N Sather
1 reference
J N Lukens
1 reference
L Wolff
1 reference
M E Trigg
1 reference
1 June 1997
1 reference
15
1 reference
6
1 reference
2222-2230
1 reference
Identifiers
1 reference